Zhimeng Biopharma has completed the patients enrollment of its investigational drug, CB03-154, in the pivotal Phase 2/3 ALS clinical trial. SHANGHAI, Oct. 31, 2026 /PRNewswire/ — Shanghai Zhimeng Biopharma, Inc. ( "Zhimeng Biopharma")… CISION PRNewswireOctober 31, 2026
Press Release ScienceOra Demonstrates AI-Assisted Hydrogen-Production Catalyst Design Workflow at Tencent Global Digital Ecosystem Summit The workflow spans literature analysis, candidate design, experimental planning and industrial decision… CISION PRNewswireOctober 31, 2026
Business Press Release PFPFA CEO Jeffrey Chow Wins New Entrepreneur Category at Entrepreneur of the Year Award 2026, Recognised for Business Growth and Entrepreneurial Vision SINGAPORE, Oct. 31, 2026 /PRNewswire/ — Jeffrey Chow, Chief Executive Officer of… CISION PRNewswireOctober 31, 2026
Press Release Agoda Reports Rise in International Travel Interest to Kaohsiung and Taipei During BTS and BIGBANG Concerts SINGAPORE, Oct. 31, 2026 /PRNewswire/ — Concerts are not only bringing fans… CISION PRNewswireOctober 31, 2026
Cake Digital Bank Wins Gold at Qorus-Infosys Finacle Banking Innovation Awards 2026 ROME, Oct. 31, 2026 /PRNewswire/ — Cake Digital Bank, a digital-only bank… CISION PRNewswireOctober 31, 2026
KSAT and Morehead State University Partner to Expand Lunar Communications Infrastructure Partnership strengthens the KSAT Lunar Network and supports deep space and lunar… CISION PRNewswireOctober 31, 2026
OCI Announces EGM Approval and Updated Indicative Timetable for Orascom Construction Combination AMSTERDAM, Oct. 31, 2026 /PRNewswire/ — OCI N.V. ("OCI" or the "Company")… CISION PRNewswireOctober 31, 2026
SMTC Recognized with Frost & Sullivan's 2026 North America Company of the Year Recognition for Mid-tier Electronic Manufacturing Services SMTC is redefining the value of a mid-sized EMS partner by combining… CISION PRNewswireOctober 31, 2026
